Pfizer's "game-changing" COVID-19 pill, Paxlovid, gets DCGI nod

Pfizer had last year announced a deal with MPP, a UN-backed body, to issue royalty-free voluntary licences to manufacture generic versions of Paxlovid in 95 middle- and low-income countries, including India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MKQFtj9
via IFTTT